Bianchi, Roberta

Research Interests

• Podoplanin function in lymphangiogenesis and cancer progression
• Podoplanin binding partners

Education & Positions held

2009-present
Ph.D. thesis with Prof. Michael Detmar Institute of Pharmaceutical Sciences, Pharmacogenomics, Swiss Federal Institute of Technology (ETH) Zurich, Switzerland

Member of the Cancer Biology Program

2009
Master degree in Medical Biotechnologies. Degree thesis „TSG-6 as a modulator of the interaction between the soluble receptor PTX3 and the angiogenic factor FGF2” carried out under the supervision of Prof. Marco Presta, Unit of General Pathology and Immunology, Department of Biomedical Sciences and Biotechnology, School of Medicine, University of Brescia, Italy.

2009
Training student (UICC-ICRETT Fellowship) in Prof. Ballmer-Hofer group, Molecular Cell Biology Group, Paul Scherrer Institut, 5232 Villigen-PSI, Switzerland

2007-2009
Second level degree course (Master) in Medical Biotechnologies,School of Medicine, University of Brescia, Italy.

2007
Bachelor Degree in Biotechnologies, Degree thesis „Characterization of novel synthetic peptides with FGF2-antagonist activity derived from the soluble receptor PTX3” carried out under the supervision of Prof. Marco Presta, Unit of General Pathology and Immunology, Department of Biomedical Sciences and Biotechnology, School of Medicine, University of Brescia, Italy.

2004-2007
First level degree course (Bachelor) in Biotechnologies, School of Medicine, University of Brescia, Italy.

Publications

Cueni L, Chen L, Zhang H, Marino D, Huggenberger R, Alitalo A, Bianchi R, Detmar M. (2010) Podoplanin-Fc reduces lymphatic vessel formation in vitro and in vivo and causes disseminated intravascular coagulation when transgenically expressed in the skin, Blood, 116: 4376-4384.

Leali D, Bianchi R, Bugatti A, Nicoli S, Mitola S, Ragona L, Tomaselli S, Gallo G, Rivieccio V, Zetta L and Presta M. (2009) Fibroblast Growth Factor 2-antagonist Activity of a Long-Pentraxin 3-derived Antiangiogenic Pentapeptide. J Cell Mol Med, 2009 Jul 20; Epub ahead of print; PMID: 19627396.